Rational therapy of hypertensive crisis in the light of modern recommendations

  • Authors: Lyamina N.P.1,2, Nalivaeva A.V.3
  • Affiliations:
    1. Research institute for cardiology of Saratov V.I.Razumovsky State medical university of the Ministry of Health of Russia
    2. Saratov V.I. Razumovsky State medical university of the Ministry of Health of Russia
    3. Saratov V.I.Razumovsky State medical university of the Ministry of Health of Russia
  • Issue: No 6 (2017)
  • Pages: 70-75
  • Section: Articles
  • URL: https://journals.eco-vector.com/2412-4036/article/view/279083
  • ID: 279083

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Hypertensive crisis is determined as one of the life-threatening complication of arterial hypertension. It is characterized by symptomatic arterial pressure increase with target organs damage including (or without it) which by themselves could cause a direct or potential life danger. Doctors of common practice, urgent aid and also patients by themselves in outpatient conditions are often facing with a problem of safe and effective decrease of arterial pressure in urgent situation. Current review contains information about national and European recommendations for hypertensive crisis relief, and also the results of large-scale researches of capoten (captopril) medicament.

Full Text

Restricted Access

About the authors

Nadezda P. Lyamina

Research institute for cardiology of Saratov V.I.Razumovsky State medical university of the Ministry of Health of Russia; Saratov V.I. Razumovsky State medical university of the Ministry of Health of Russia

Email: lyana_n@mail.ru
MD, professor, deputy director for scientific work; professor of the Chair of intermediate level therapy of general medicine department

Anna V. Nalivaeva

Saratov V.I.Razumovsky State medical university of the Ministry of Health of Russia

PhD candidate of the Chair of intermediate level therapy of general medicine department

References

  1. Чазова И.Е., Жернакова Ю.В., Ощепкова Е.В. и др. Распространенность факторов риска развития сердечно-сосудистых заболеваний в российской популяции больных артериальной гипертонией. Кардиология. 2014;54(10):4-12. [Chyazova I. E., Zhernakova Ju.V., Oshepkova E.V. and others. Prevalence of risk factors of cardiovascular diseases development in Russian population of patients with arterial hypertension. Cardiology. 2014;54(10):4-12.]
  2. Лямина Н.П., Наливаева А.В., Котельникова Е.В. Патогенетические аспекты и особенности вегетативной регуляции при маскированной артериальной гипертензии в женской популяции зрелого возраста. Фундаментальные исследования. 2015;1(8):1722-29. [Lyamina N.P., Nalivaeva A.V., Kotelnikova E.V. Pathogenetic aspects and peculiarities of vegetative regulation in case of masked arterial hypertension in mature age female population. Fundamental research works. 2015;1(8):1722-29.]
  3. Mancia G., Fagard R., Narkiewicz К., Redon J., Zanchetti A., Böhm M., Christiaens T., Cifkova R., De Backer G., Dominiczak A., Galderisi M., Grobbee D.E., Jaarsma T., Kirchhof P., Kjeldsen S.E., Laurent S., Manolis A.J., Nilsson P.M., Ruilope L.M., Schmieder R.E., Sirnes P.A., Sleight P., Viigimaa M., Waeber B., Zannad F.; Task Force Members. 2013 ESH / ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2013;31(7):1281-1357.
  4. Reddy V.S., Jacob G.P., Ballala K. et al. A study on the prevalence of hypertension among young adults in a coastal district of Karnataka, South India. Int. J. Healthcare Biomed. Res. 2015;3(3):32-9.
  5. Лямина С.В., Лямина Н.П., Сенчихин В.Н., Додина К.А. Вариабельность артериального давления и сосудистый кровоток в молодом возрасте при артериальной гипертонии. Фундаментальные исследования. 2009;10:16-20.
  6. Лямина Н.П., Наливаева А.В., Сенчихин В.Н., Липчанская Т.П. Маскированная артериальная гипертензия у лиц молодого возраста: распространенность, выраженность кардиоваскулярных факторов риска и прогноз с учетом гендерных различий. Российский кардиологический журнал. 2017;144(4):7-12. [Lyamina N.P., Nalivaeva A.V., Senchykhin V.N, Lipchyanskaya T.P., Masked arterial hypertension in young age individuals: prevalence, degree of cardiovascular risk factors and prognosis with gender differences considering. Russian Cardiological Journal. 2017;144(4):7-12.]
  7. Martin J.F., Higashiama E., Garcia E., Luizon M.R., Cipullo J.P. Hypertensive crisis profile: prevalence and clinical presentation. Arq. Bras. Cardiol. 2004;83(2): 31-6.
  8. Sobrinho S., Correia L.C., Cruz C., Santiago M., Paim A.C., Meireles B., Andrade M., Kerner M., Amoedo P., de Souza C.M. Occurrence rate and clinical predictors of hypertensive pseudocrisis in emergency room care. Arq. Bras. Cardiol. 2007;88(5):579-84.
  9. De Macedo C.R., Noblat A.C., Noblat L., de Macedo J.M., Lopes A.A. Use of oral antihypertensive medication preceding blood pressure elevation in hospitalized patients. Arq. Bras. Cardiol. 2001;77(4):324-31.
  10. Недогода С.В., Верткин А.Л., Баранова Е.И., Кобалава Ж.Д., Конради А.О., Арутюнов Г.П., Галявич А.С., Дупляков Д.В., Козиолова Н.А., Лопатин Ю.М., Стаценко М.Е., Тарловская Е.И., Уметов М.А., Чесникова А.И., Фомин И.В. Алгоритмы ведения пациента с гипертоническим кризом. Общероссийская общественная организация содействия профилактике и лечению артериальной гипертензии «Антигипертензивная Лига». Санкт- Петербург, 201 5. 32 с.
  11. Алмазов В.А., Шляхто Е.В. Гипертоническая болезнь. М.: Медицина. 2000. 1 18 с. [Almazov V.A., Schlyachto E.V. Hypertensive disease. M.: Medicine. 2000. 118 с.]
  12. Космалева Н.Г., Родионова И.И., Наумова И.И. Опыт применения таблетированных форм капотена и нифедипина при артериальной гипертензии у лиц старшего возраста. Здравоохранение Чувашии. 2010;2. [Kosmalyova N.G., Rodionova I.I., Naumova I.I. The experience of tableted capoten and nifedipine forms use in elderly arterial hypertensive patients. Healthcare of Chuvashia. 2010;2.]
  13. Gemici K., Baran I., Bakar M., Demircan C., Ozdemir B., Cordan J. Evaluation of the effect of the sublingually administered nifedipine and captopril via transcranial doppler ultrasonography during hypertensive crisis. Blood Press. 2003;12(1):46-8.
  14. Гипертонический криз на догоспитальном этапе. Практические рекомендации по диагностике, лечению и профилактике для врачей первичного звена здравоохранения. ГОУ ВПО МГМСУ Росздрава. Национальное научно-практическое общество скорой медицинской помощи. М., 2009. [Hypertensive crisis at prehospital stage. Practical recommendations for diagnostics, treatment and prevention for primary care physicians. MSUMD Higher Vocational School of Roszdrav. National scientific-practical ambulance society. M., 2009.]
  15. Kaya A., Tatlisu M.A., Kaplan Kaya T., Yildirimturk O., Gungor B., Karatas B., Yazici S., Keskin M., Avsar S., Murat A. Sublingual vs. Oral Captopril in Hypertensive Crisis. J. Emerg. Med. 2016;50(1):108-15.
  16. Karakiliç E., Büyükcam F., Kocalar G., Gedik S., Atalar E. Same effect of sublingual and oral captopril in hypertensive crisis. Eur. Rev. Med. Pharmacol. Sci. 2012;16(12):1642-5.
  17. Addad F., Ferjani H., Chaabani A., Jelliti M., Gamra H., Makni H., Khaldoun B.H., Dridi Z., Ben Farhat M. A comparison of the effect of oral captopril and nicardipine in hypertensive crisis. Tunis Med. 2008;86(2):1 50-4.
  18. Onzenoort H.A., Bussink M., Menheere P.P., van Mook W.N., van der Kuy P.H. The effect of sublingual captopril versus intravenous enalaprilat on angiotensin II plasma levels. Pharm. World Sci. 2006;28(3):131-4.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies